Here we present the effects of low dose zibotentan in combination with dapagliflozin on a range of cardiometabolic risk factors.Method In a post-hoc analysis of the ZENITH-CKD trial, a randomized, double-blind, active-controlled trial conducted in 170 clinical sites in 19 countries, adults ...